Cargando…
Palbociclib in the treatment of recurrent ovarian cancer
Serous ovarian cancers are typically high grade and recur within a short interval. The currently available therapeutic options provide a relatively low response rate and the progress-free survival are short-lived. There is emerging data that CDK4/6 may be effective in metastatic ovarian cancer. This...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486429/ https://www.ncbi.nlm.nih.gov/pubmed/32953960 http://dx.doi.org/10.1016/j.gore.2020.100626 |